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Background: Recently, we reported an information density theory and an analysis of three-parameter plus shorter
scan than conventional method (3P+) for the amyloid-binding ligand [11C]Pittsburgh compound B (PIB) as an
example of a non-highly reversible positron emission tomography (PET) ligand. This article describes an extension
of 3P + analysis to noninvasive ‘3P++’ analysis (3P + plus use of a reference tissue for input function).
Methods: In 3P++ analysis for [11C]PIB, the cerebellum was used as a reference tissue (negligible specific binding).
Fifteen healthy subjects (NC) and fifteen Alzheimer's disease (AD) patients participated. The k3 (index of receptor
density) values were estimated with 40-min PET data and three-parameter reference tissue model and were
compared with that in 40-min 3P + analysis as well as standard 90-min four-parameter (4P) analysis with arterial
input function. Simulation studies were performed to explain k3 biases observed in 3P++ analysis.
Results: Good model fits of 40-min PET data were observed in both reference and target regions-of-interest (ROIs).
High linear intra-subject (inter-15 ROI) correlations of k3 between 3P++ (Y-axis) and 3P + (X-axis) analyses were
shown in one NC (r2 = 0.972 and slope = 0.845) and in one AD (r2 = 0.982, slope = 0.655), whereas inter-subject k3
correlations in a target region (left lateral temporal cortex) from 30 subjects (15 NC + 15 AD) were somewhat lower
(r2 = 0.739 and slope = 0.461). Similar results were shown between 3P++ and 4P analyses: r2 = 0.953 for intra-subject
k3 in NC, r
2 = 0.907 for that in AD and r2 = 0.711 for inter-30 subject k3. Simulation studies showed that such lower
inter-subject k3 correlations and significant negative k3 biases were not due to unstableness of 3P++ analysis but
rather to inter-subject variation of both k2 (index of brain-to-blood transport) and k3 (not completely negligible) in
the reference region.
Conclusions: In [11C]PIB, the applicability of 3P++ analysis may be restricted to intra-subject comparison such as
follow-up studies. The 3P++ method itself is thought to be robust and may be more applicable to other non-highly
reversible PET ligands with ideal reference tissue.
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Various reversible-type radioligands have been developed
for in vivo neuroreceptor study with positron emission
tomography (PET). Both arterial blood sampling and long
dynamic PET scan, up to 120 min, are required for stand-
ard nonlinear least-squares (NLS) analysis to estimate K1
to k4 in the two-tissue compartment four-parameter
model (4P model): K1 represents the blood-to-brain trans-
port constant, k2 represents the brain-to-blood transport
constant, k3 represents the first-order association rate con-
stant for specific binding, and k4 represents the dissoci-
ation rate constant for specific binding. The k3 represents
Bmax∙kon, where Bmax is maximum receptor density and
kon is the in vivo association rate constant. Since k3 repre-
sents available receptors for the PET ligand, it is the target
parameter of major interest in most PET studies. However,
quantification of k3 in the 4P model is often difficult
because of uncertainty of the k4 estimate and high correl-
ation between the k3 and k4 estimates. As surrogate
parameters for Bmax, binding potential and distribution
volume have been widely used [1-4]. Several reference tis-
sue methods have also been developed [5-10].
Irreversible (enzyme-substrate type) radiotracers [11C]
methylpiperidin-4-yl acetate and propionate have been
developed for the measurement of cerebral acetylcholine
esterase activity using PET [11,12]. In this case the two-
tissue compartment three-parameter (K1 to k3) model
(3P model) was used to estimate k3, which is an index of
acetylcholine esterase activity. In the 3P model, the pre-
cision of k3 estimate is usually higher than in the 4P
model, in spite of shorter PET scan time (40 to 60 min),
since there is no need of k4 estimation in the 3P model.
We have previously defined two mathematical functions,
the information density function and information func-
tion, which are useful for model selection and opti-
mization of scan time in PET [13]. Based on simulations
using both functions, we proposed a new method (3P +
method) for quantification of k3 for moderately reversible
ligands. ‘3P+’ means three-parameter model plus short
PET scan. In this method, the 3P model (k4 = 0 model)
was applied to the early-phase PET data (up to 30 to 40
min) from reversible ligands with moderate k4 (moderately
reversible ligands). Although the 3P +method was not al-
ways developed for a specific ligand, the amyloid-binding
radiotracer [11C]Pittsburgh compound B (PIB) was used as
an example for the moderately reversible ligands (k4 =
0.018/min). The 3P +method afforded a more stable k3 es-
timate than the standard 90-min 4P analysis. However,
there is still the drawback of the necessity for arterial blood
sampling and radiometabolite analysis, which may restrict
the widespread use of this method in daily clinical practice.
In this article, we propose a noninvasive 3P++ analysis
using [11C]PIB. 3P++ means 3P + analysis plus use of
a reference tissue for input function. To validate theproposed method, the linear correlations of k3 estimates
were evaluated between 40-min 3P++ and 3P + analyses,
as well as between 3P++ and 90-min 4P analyses in clin-
ical PET studies. In addition, simulation studies were per-
formed to explain k3 biases observed in the 3P++ analysis.
Methods
Theory
Assumptions in 3P++ analysis
The following are assumptions used in 3P++ analysis:
 Assumption 1 (on the nature of radioligand used): We
apply 3P++ analysis only to moderately reversible or
nearly irreversible radioligands (k4 ≤ 0.03/min), but
exclude highly reversible ligands. [11C]PIB is an
example of moderately reversible ligands
(k4 = 0.018/min).
 Assumption 2 (on the duration time of PET scan):
We use early-phase PET data in the curve fitting. In
[11C]PIB, dynamic PET data during 0 to 40 min was
described well with the 3P model, since the effect of
the k4 process on PET data was negligible within
these early-phase kinetics [13].
 Assumption 3 (on the specific binding in the
reference tissue, k3r): Specific binding of radioligand is
negligible in the reference tissue (k3r = 0). In [
11C]PIB,
the gray matter of the cerebellum is usually used as a
reference tissue for input function [14]. We apply the
one-tissue compartment two-parameter (K1, k2)
model (2P model) to the reference tissue.
Working equation for 3P++ analysis
The working equation for the 3P++ analysis has been
reported [15]:







¼ R1Cr tð Þ þ R1k2rk3k2 þ k3
Zt
0




e− k2þk3ð Þ t−τð ÞCr τð Þdτ;
ð1Þ
where Ct(t) is the radioactivity concentration in the tar-
get tissue and Cr(t) is that in the reference tissue; k2r is
the k2 in the reference tissue and ⊗ is the convolution
integral. The rate of tracer penetration into the target
tissue is obtained as the relative value R1, which is the
ratio of target K1 to reference K1.
Clinical PET study
Human subjects
Two groups of subjects, a normal control (NC) group
and an Alzheimer's disease (AD) group, participated in
Sato et al. EJNMMI Research 2013, 3:76 Page 3 of 10
http://www.ejnmmires.com/content/3/1/76the current study with written informed consent. The
NC group consisted of 15 healthy subjects (age ranging
from 48 to 90 years, 66.7 ± 11.5 years (mean ± SD); eight
males and seven females) without a history of central
nervous system diseases or psychiatric disorders, and the
AD group consisted of 15 patients (ages 55 to 85, 68.9 ±
9.6 years; four males and 11 females) diagnosed as prob-
able AD according to the criteria of the National Insti-
tute of Neurological and Communication Disorders,
Alzheimer's Disease and Related Disorders Association
[16]. The study was approved by the Institutional Review
Board of the National Institute of Radiological Sciences.
Radiochemical synthesis
[11C]PIB was synthesized by the reaction of 2-(4′-ami-
nophenyl)-6-hydroxy-benzothiazole and [11C]methyl tri-
flate [17]. The product had radiochemical purity greater
than 95.4%. Specific activity was in the range of 56.3 to
285.3 GBq/μmol.
PET scan protocol
PET images were acquired with a Siemens ECAT
EXACT HR + scanner (CTI PET systems, Inc., Knoxville,
TN, USA) with an axial field of view of 155 mm, provid-
ing 63 contiguous 2.46-mm slices with 5.6-mm tran-
saxial and 5.4-mm axial resolution. After a 10-min
transmission scan for tissue attenuation correction, infu-
sion of [11C]PIB (about 370 MBq in 5 mL for 1 min)
began. A PET scan in 3D mode was started after the arrival
of tracer to the brain (approximately 30 s after the begin-
ning of tracer infusion). The dynamic scans consisted of 19
frames (3 × 20 s, 3 × 40 s, 1 × 1 min, 2 × 3 min, 5 × 6 min,
and 5 × 10 min) with the total scan duration of 90 min. All
data processing and image reconstruction were performed
using standard Siemens software, which included scatter
correction, randoms, and dead time correction.
Region-of-interest delineation
Region-of-interest (ROI) analysis was performed using the
PMOD software package (PMOD version 3.2; Technolo-
gies Ltd., Adliswil, Switzerland). The [11C]PIB PET images
were co-registered to T1 weighted images in each subject.
The following 15 ROIs were drawn manually on T1
weighted images: frontal, mesial temporal, lateral temporal,
parietal, occipital, anterior cingulate, and posterior cingu-
late cortices in both hemispheres as well as the reference
tissue (gray matter of cerebellum). ROIs were transferred
to co-registered [11C]PIB PET images, and time-activity
curves (TACs) were obtained in those brain regions.
Input function measurement
During PET scan, arterial blood was collected from radial
artery, starting 6 s (transit delay at the blood sampling site)
after the beginning of PET scan to 85 min post injection(10 × 10 s, 1 × 30 s, 9 × 2 min, 6 × 10 min, and 1 × 5 min;
27 samples). Radioactive metabolites were analyzed by a
radio-thin layer chromatography (TLC) method [12], with
a TLC-developing solvent (ethyl acetate/n-hexane = 2:1
vols). The metabolite-corrected radioactivity as well as
total radioactivity in blood plasma was fitted to a mono-
exponential saturation function during infusion (0 to 1
min) and the sum of three-exponential functions after the
end of infusion (1 to 85 min) [12].
4P and 3P + analyses (arterial-plasma input)
Brain regional TACs were analyzed by the weighted NLS
method under positive constraint of all ki with metabolite-
corrected input function to afford K1 to k4 estimates in 4P
analysis (scan time of 90 min) and K1 to k3 estimates in
3P + analysis (40 min). Correction was made for blood-
pool (5%) radioactivity in brain tissue [14]. Custom soft-
ware operating in IDL software (version 6.0; Jicoux
Datasystems, Inc., Tokyo, Japan) environment was used
for the compartment model analysis.
3P++ analysis (reference tissue input)
For successful convergence in NLS optimization using
Equation 1, we fixed k2r to 0.178/min (mean cerebellar k2
value by 40-min 3P + analysis; N = 30; SD = 0.034). Based
on Equation 1 and cerebellar TAC with a fixed k2r value,
the time-integral of Cr(t) (the second term on the right
side of Equation 1) and the convolution integral (the third
term) were calculated numerically without data inter-
polation for each scan mid-times during 0 to 40 min, and
the three parameters R1, k2, and k3 were estimated.
Simulation study
Generation of error-added TACs for Monte Carlo simulation
The error-free, baseline TACs (19 frames/90 min) simulat-
ing the target ROI of the NC and AD subjects were gener-
ated by using the 4P model with parameter set (K1 = 0.180
mL/g/min, k2 = 0.180/min, k3 = 0.018 and 0.036/min for
the NC and AD subjects, respectively, and k4 = 0.018/min;
typical values for [11C]PIB) and averaged (N = 20) input
function of [11C]PIB. The reference ROI was the same be-
tween NC and AD subjects and was generated by using
the 2P model with parameter set (K1 = 0.180 mL/g/min,
k2 = 0.180/min) and the same input function as above. The
error-added TACs for simulation were generated accord-
ing to the following formula [18]:
Error‐added Ci ¼ Ci þ Rand σ Cið Þ;
σ Cið Þ ¼ ε
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
Ci
Δti  exp −λtið Þ ;
s
ð2Þ
where Ci is noise-free simulated radioactivity concentra-
tion at frame number i, Rand is a random number from a
Gaussian distribution with a mean 0 and variance 1, ε is a
Figure 1 Reference and target tissue TACs in [11C]PIB PET. (A)
Cerebellar (reference tissue) data (open circle) up to 90 min in one
AD subject and the fit of 40-min data to the 2P model (solid line).
(B) Cerebral cortical (target tissue) data (open circle) in the same
subject and the fits of 40-min data to the 3P model with
arterial-plasma input (3P + analysis; solid line) or reference tissue input
(3P++ analysis; dashed line). The dotted lines in (A) and (B) indicate
the extension of the solid line from 40 to 90 min.
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duration of frame number i, ti is mid-scan time of frame
number i, and λ is 11C decay constant. In all Monte Carlo
simulations, a data set of 100 noise-added TACs was ana-
lyzed with weighted NLS, using a relative weight wi:
wi ¼ constant Δti  exp −λtið ÞCi : ð3Þ
Effects of PET noise on 4P, 3P+, and 3P++ analyses
Five levels of PET noise (0.025, 0.05, 0.1, 0.2, and 0.3; ε in
Equation 2, relative values empirically determined) were
added to the baseline TACs of the target ROI of the NC
subjects. From 100 error-added TACs for each PET noise
level, 100 k3 values were estimated using 90-min 4P, 40-
min 3P+, and 3P++ analyses. Coefficient-of-variation (CV)
of k3 was calculated as CV (%) = (SD/mean) × 100. In the
following simulations, the PET noise was fixed at 0.1.
Effects of K1 change in target ROI on 4P, 3P+, and 3P++
analyses
Simulated target TACs were generated by 4P model with
five different K1 values (0.12, 0.15, 0.18, 0.21, and 0.24
mL/g/min) and fixed k3 (0.018/min) and k4 (0.018/min).
The value of K1/k2 was fixed at 1. The range of K1 was
determined with clinically measured K1 for [
11C]PIB
(0.177 ± 0.31 in NC group and 0.168 ± 0.30 in AD group;
90-min 4P analysis). Reference TAC was the same as
baseline reference TAC. The k3 bias in 90-min 4P, 40-
min 3P+, and 3P++ analyses relative to the true k3
(0.018/min) was calculated as bias (%) = (estimated k3/
true k3 − 1) × 100.
Effects of k2 or k3 change in reference ROI on 3P++ analysis
In 3P++ analysis, k3r was assumed to be 0 and k2r was
fixed as an empirical constant. The effects of k2r or k3r
change were investigated as follows. The error-added tar-
get TACs were generated by 4P model with two different
k3 values (0.018/min for NC and 0.036/min for AD); other
parameters were the same as the baseline target TAC. The
error-added reference TACs were generated by 2P model
with five different k2 (0.12, 0.15, 0.18, 0.21, and 0.24/min)
and fixed K1 values (0.18 mL/g/min). Another set of simu-
lated reference TACs was generated by 3P model (not 2P
model) with five different k3 (0, 0.002, 0.004, 0.006, and
0.008/min) and fixed K1 (0.18 mL/g/min) and k2 (0.18/
min). The k3 bias in 3P++ analysis was expressed relative
to 3P + analysis as bias (%) = (3P++ k3/3P + k3 − 1) × 100.
Although k3r was assumed to be 0 in Equation 1, each
subject may have different k3r values that deviated from
0. In simulations to investigate the effect of the individ-
ual k3r variation on 3P++ analysis, we defined the k3
value empirically corrected for nonzero k3r as follows:k3′ = k3 + k3r, where k3 is the k3 estimate of target ROI by
3P++ analysis and k3r is the k3 estimate of reference ROI
by 3P + analysis (true reference k3). Bias in 3P++ k3′
relative to 3P + k3 was compared with the bias in 3P++
k3 to 3P + k3.
Results
Goodness of model fits in 3P++ analysis
Figure 1A shows an example of the curve fitting of [11C]
PIB cerebellar TAC data to the 2P model, where a good fit
is seen during 0 to 40 min after tracer injection. Figure 1B
shows the fits of cerebral cortical TAC data (0 to 40 min)
to the 3P + and 3P++ models. The goodness-of-fit by 3P++
model (reference tissue input) is almost indistinguishable
from that by 3P +model (arterial-plasma input). Kinetic
parameters (K1 = 0.161 mL/g/min, k2 = 0.167/min and
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0.897, k2 = 0.158/min and k3 = 0.011/min in 3P++ analysis.
Intra-subject k3 correlation
Figure 2A is an example of the intra-subject k3 correl-
ation between 40-min 3P + (X-axis) and 3P++ (Y-axis)
analyses, where the k3 values of 15 ROIs, including the
cerebellum (reference tissue in 3P++ analysis) from one
particular NC subject or one particular AD subject, are
shown. The regression lines and the coefficients of de-
termination are Y = 0.845X − 0.006 (r2 = 0.972) for the
NC subject and Y = 0.655X − 0.004 (r2 = 0.982) for the
AD subject. Cerebellar k3 values for both subjects are
naturally calculated to be 0 in the 3P++ analysis. The
slopes of the regression lines indicate the presence of
negative bias in the 3P++ against the 3P + analysis.
Figure 2B shows the k3 correlation between 90-min 4P
(X-axis) and 40-min 3P++ (Y-axis) analyses in the same
subjects. The regression lines are Y = 0.590X − 0.005 (r2 =
0.953) for the NC subject and Y = 0.338X + 0.000 (r2 =
0.907) for the AD subject. When the cerebellar data
(X = 0.008, Y = 0.000) was removed from calculation for
the AD subject, the regression line became Y = 0.295X −
0.002 with slightly larger r2 (0.935; not shown in the
figure). The slopes of the regression lines show that k3 bias
in 3P++ against 4P analysis is larger than that against
3P + analysis.
Inter-subject k3 correlation
Figure 3A shows an example of the inter-subject k3 cor-
relation, where k3 values for the left lateral temporal
cortex from 30 subjects (15 NC + 15 AD) are compared
between 40-min 3P + (X-axis) and 3P++ (Y-axis) ana-
lyses. The regression lines are Y = 0.461X − 0.001 (r2 =
0.739) for all 30 subjects, Y = 0.178X + 0.000 (r2 = 0.151)Figure 2 Intra-subject correlation of k3 for 15 ROIs in [
11C]PIB PET. Th
40-min 3P++ vs. 90-min 4P analyses (B) with one NC subject (open circle)for the NC group alone, and Y = 0.286X + 0.003 (r2 =
0.411) for the AD group alone; the latter two lines are not
shown in the figure. The slopes of the regression lines also
indicate the presence of negative biases in 3P++ against
3P + analysis.
Figure 3B shows the inter-subject correlation of left
lateral temporal k3 between 90-min 4P (X-axis) and 40-
min 3P++ (Y-axis) analyses, where the regression line is
Y = 0.225X + 0.000 (r2 = 0.711) for all subjects. The lines
of Y = 0.090X + 0.001 (r2 = 0.122) for the NC group alone
and Y = 0.135X + 0.005 (r2 = 0.513) for the AD group
alone were also calculated. The slopes of the regression
lines show larger negative k3 biases in 3P++ against 4P
analysis than that shown in Figure 3A. The results in
other cerebral regions were essentially the same as those
in the left lateral temporal cortex.
Simulation on the effects of PET noise on k3 CV
Figure 4 compares the noise sensitivity of k3 estimates
among the 90-min 4P, 40-min 3P+, and 3P++ analyses. In
all three analyses, the k3 CVs increased as the PET error
became larger. The k3 CV in 3P++ analysis was compar-
able to that in 3P + analysis and lower than that in 4P ana-
lysis; for example, k3 CVs at 0.1 of noise level were 6.6% in
3P++, 7.0% in 3P+, and 11.4% in 4P analyses.
Simulation on the effects of target K1 change on k3 bias
Figure 5 shows the effects of K1 change in the target
ROI on the k3 biases in the 90-min 4P, 40-min 3P+, and
3P++ analyses. The 4P analysis remained almost bias-
free (+0.6%) within K1 from 0.12 to 0.24 mL/g/min. 3P
+ and 3P++ analyses showed larger negative biases
(−33% to −34% bias in 3P + and −33% to −35% bias in
3P++) compared with 4P analysis. Although 3P++ ana-
lysis showed slightly larger k3 bias than 3P + analysise results in 40-min 3P++ (Y-axis) vs. 3P + (X-axis) analyses (A) and
and one AD subject (closed circle) are shown.
Figure 3 Inter-subject correlations of left lateral temporal k3 in [
11C]PIB PET. The results in 40-min 3P++ (Y-axis) vs. 3P + (X-axis) analyses
(A) and 40-min 3P++ vs. 90-min 4P analyses (B) with 30 subjects (15 NC, open circle; 15 AD, closed circle) are shown.
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lysis was almost the same as 3P + analysis.
Simulation on the effects of k2r change on 3P++ analysis
In 3P++ analysis (Equation 1), k2r was fixed at 0.178/
min, though k2r was not always the same among subjects
(CV = 19%). Figure 6 shows the effects of individual k2r
change in 40-min 3P++ analysis. When k2r was equal to
the fixed value (0.18/min), 3P++ analysis was bias-free,
relative to 3P + analysis. However, when k2r was different
from the fixed value, 3P++ analysis showed a negative k3
bias relative to 3P + k3. The k2r effects were similarFigure 4 Effects of PET noise on CV of k3. The results in 40-min
3P++ (open triangle), 40-min 3P + (open square), and 90-min 4P
(open circle) analyses are shown. Five different PET noises (0.025 to
0.3) were added to the [11C]PIB baseline TACs of the target ROI of
the NC subjects. CV of k3 was calculated from 100 k3 estimates as
CV (%) = (SD/mean) × 100.between NC ROI (k3 = 0.018/min) and AD ROI (k3 =
0.036/min); for example, the biases were −14.1% for NC
and −12.1% for AD at k2r = 0.12/min and −14.1% for NC
and −11.3% for AD at k2r = 0.24/min.
Simulation on the effects of k3r change on 3P++ analysis
In 3P++ analysis we assume that k3r = 0, that is, specific
binding is negligible in the reference tissue. However, in
all subjects examined, this assumption did not hold: the
k3r values in 40-min 3P + analysis were 0.008 ± 0.004/min
in the AD group, 0.007 ± 0.002/min in the NC group, and
0.007 ± 0.003/min in the AD+NC group.Figure 5 Effects of K1 change in the target region on k3 bias.
The results in 40-min 3P++ (open triangle), 40-min 3P +
(open square) and 90-min 4P (open circle) analyses are shown.
Simulated target TACs were generated by 4P model with five
different K1 values (0.12 to 0.24 mL/g/min). The k3 bias was
calculated as bias (%) = (estimated k3/true k3 – 1) × 100.
Figure 6 Effects of k2 change in the reference region on k3 bias
in 40-min 3P++ analysis. Simulated target TACs were generated by
4P model with two different k3 values (0.018/min for NC, open circle;
0.036/min for AD, closed circle). Simulated reference TACs were
generated by 2P model with five different k2 values (0.12 to 0.24/
min). The k3 bias in 3P++ analysis was expressed relative to 3P +
analysis as bias (%) = (3P++ k3/3P + k3 – 1) × 100.
Figure 7 Effects of k3 change in the reference region on k3 bias
in 40-min 3P++ analysis. Simulated target TACs were generated by
4P model with two different k3 values (0.018/min for NC, open circle;
0.036/min for AD, closed circle). Simulated reference TACs were
generated by 3P model with five different k3 values (0 to 0.008/min).
The k3 bias in 3P++ analysis was expressed relative to 3P + analysis
as bias (%) = (3P++ k3/3P + k3 – 1) × 100. Effects on bias in 3P++ k3′
relative to 3P + k3 are also shown (NC, open triangle; AD, closed
triangle), where 3P++ k3′ was calculated as (3P++ k3′) = (3P++
k3) + reference k3.
Figure 8 Inter-subject correlation of left lateral temporal k3 in
[11C]PIB PET. The result in 40-min 3P++ (Y-axis) vs. 3P + (X-axis)
analyses with 30 subjects (15 NC, open circle; 15 AD, closed circle) is
shown. The k3 estimates were empirically corrected as (3P++ k3′) =
(3P++ k3) + (individual cerebellar k3 by 3P+).
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0.008/min) on 40-min 3P++ analysis. When k3r was 0, 3P++
analysis was bias-free, relative to 3P + analysis. The k3
biases (negative biases) increased as k3r increased: −38%
for NC and −27% for AD at k3r = 0.004/min and −70% for
NC and −48% for AD at k3r = 0.008/min. The NC ROI
(k3 = 0.018/min) showed larger biases than the AD ROI
(k3 = 0.036/min). Figure 7 also shows the results of the
simulation study on the relationship between 3P++ k3′
and 3P + k3, where 3P++ k3 was empirically corrected with
individual k3r. In this case, negative bias in 3P++ k3′ was
significantly decreased compared to that in 3P++ k3; for
example, bias was decreased from −70% to −7% for NC,
and from −48% to −15% for AD at k3r = 0.008/min.
Figure 8 shows the correlation between 3P++ k3′ and
3P + k3 using the same data as in Figure 3A, where 3P++
k3 in Figure 3A was replaced by 3P++ k3′. The regres-
sion line was Y = 0.678X + 0.003 (r2 = 0.975) for all sub-
jects, where X = 3P + k3 and Y = 3P++ k3′. The lines of Y
= 0.798X + 0.002 (r2 = 0.897) for the NC group alone and
Y = 0.620X + 0.004 (r2 = 0.960) for the AD group alone
were also calculated. The determination coefficient was
increased by this correction from 0.739 to 0.975. The
slope of the regression line was also increased from
0.461 (Figure 3A) to 0.678 (Figure 8), which showed the
reduction of negative bias in 3P++ analysis.
Discussion
Theoretical basis and merits of 3P++ analysis
The previous 3P + analysis allowed for estimating k3 of
moderately reversible ligands, where the 3P model wasapplied to early-phase (up to 30 to 40 min) PET data
with arterial input function [13]. It was reported that
when the 3P model was applied to 60-min PET scan data
from [11C]PIB (k4 = 0.018/min) as a moderately revers-
ible ligand, only a poor model fit was obtained [19]. Pre-
vious simulation studies on [11C]PIB using information
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min would be necessary to obtain a good fit to the 3P
model [13].
When 3P + or 3P++ analysis can be applied to a ligand,
such ligand is specified as a moderately reversible ligand.
This applicability is determined by the information func-
tion curves of k3 and k4 [13], and thus is dependent on
the scan time as well as k3 and k4 values of the ligand in
a ROI. Differentiation of a moderately reversible ligand
from general reversible ligands is somewhat arbitrary,
though we conveniently defined this with the k4 value
(≤0.03/min) in this study.
In the present study, the 3P + plasma input model was
extended to the 3P++ reference tissue input model. The
3P++ analysis has three merits over previous methods.
First, the PET scan time is short, usually less than 40 min,
which may be important in PET studies with elderly or de-
mented subjects. Secondly, the target parameter k3 can be
isolated from the other model parameters. Thirdly, neither
arterial cannulation nor labor-intensive measurements of
labeled metabolites are required.
One of the conventional models for the estimation of
binding of [11C]PIB is the Logan plot analysis [2], which
employs data of long duration (more than 60 min). Non-
invasive Logan analysis (distribution volume ratio) [6] re-
quires late-phase (equilibrium-phase) PET data, whereas
late-phase data are not necessary for 3P++ analysis. In the
noninvasive Logan model or simplified reference tissue
model [8], the K1-to-k2 ratio in the target and reference tis-
sues is assumed to be equal. 3P++ analysis does not require
such an assumption. Since 3P++ analysis is a kind of
irreversible-model analysis, K1 (R1) and k3 can be independ-
ently estimated (k2 must be fixed to a certain constant).
Noise sensitivity of 3P++ analysis
Loss of PET data in short-scan 3P++ and 3P + analyses
might be considered to deteriorate the precision of the
k3 estimate. In the present simulation for noise sensitiv-
ity, k3 CV values in 40-min 3P++ and 3P + analyses were
lower than (almost three fifths of ) that in 90-min 4P
analysis (Figure 4), which was in accordance with the
previous report [13]. It is considered that the loss of
PET data may be compensated for by the reduction in
the number of free parameters from four in the 4P
model to three in the 3P + and 3P++ models.
K1 effect on 3P++ analysis
In the K1 simulation, the stableness of k3 estimation in
changes of cerebral blood flow was investigated. The mag-
nitudes of k3 bias were independent of the K1 change, ran-
ging from 0.12 to 0.24 mL/g/min, in 3P++, 3P+, and 4P
analyses (Figure 5). The 3P++ as well as 3P + and 4P ana-
lyses were less affected by K1, which is owing to the cap-
ability of isolating the k3 estimation. The 40-min 3P +analysis showed −33% k3 bias relative to 90-min 4P ana-
lysis, which is in accordance with the previous report [13].
In this K1 simulation, 3P++ k3 showed negligible bias rela-
tive to 3P + k3. These results suggested that in 3P++ ana-
lysis, the effects of ignoring vascular volume as well as
numerical integration error due to discrete time points
were not significant.
Causes of negative k3 bias in 3P++ analysis
Firstly, the k3 bias in 3P++ analysis originates from 3P
model approximation. Our previous simulation study
[13] showed that the 3P + analysis with 28-min scan had
large negative k3 bias relative to 4P analysis with 90-min
scan; for example, there was about −22% to −24% bias to
true k3 (4P k3) ranging from 0.01 to 0.04/min including
NC and AD k3. 3P++ analysis showed further negative
k3 bias relative to 3P + analysis due to the following two
reasons.
Secondly, the bias is due to individual k2r change from
the fixed value in Equation 1. In 3P++ analysis, we also
assumed that k2 in the reference tissue was constant and
was fixed at 0.178/min, which was the average k2 value
with the 3P +model. In simulation, negative k3 bias was
predicted when k2r was larger or smaller than fixed k2
(Figure 6). Each subject in the NC and AD groups had
different k2 values in the reference tissue, and it is con-
sidered that such biological variance as for reference tis-
sue may result in a negative k3 bias in 3P++ analysis,
relative to 3P + analysis for [11C]PIB.
Thirdly, the bias is due to the discrepancy between the
model assumption and the actual reference ROI. The basic
assumption (assumption 3) in 3P++ analysis is k3r = 0. The
working equation of 3P++ analysis (Equation 1) is derived
under this assumption, and reference k3 is naturally calcu-
lated to be 0. However, in 3P + analysis with [11C]PIB, the
cerebellum showed nonzero k3 (0.007 ± 0.003/min in all 30
subjects). Thus, 3P++ k3 is expected to be underestimated.
Simulation studies showed that 3P++ analysis was bias-free
for ideal reference with zero k3 and that k3 bias became lar-
ger as k3r increased (Figure 7). When k3 was replaced by
k3′, negative bias was significantly decreased in the simula-
tion (Figure 7), as well as the slope of the regression line
between 3P++ and 3P + analyses being increased from
0.461 (Figure 3A) to 0.678 (Figure 8), which also suggested
that nonzero k3r caused underestimation of 3P++ k3.
Correlation of k3 between 3P++ and 3P + analyses
Strong intra-subject k3 correlation was shown between
3P++ and 3P + analyses, and the rank-order of k3 was al-
most the same between the two analyses (Figure 2A),
suggesting the stability of both 3P++ and 3P + analyses.
The inter-subject k3 correlation (r
2; Figure 3A) was
significantly lower than the intra-subject correlation
(Figure 2A). Such a lower inter-subject k3 correlation
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bellar k3. In order to explain this, k3′ was calculated for
each subject. When k3 was replaced by k3′, the deter-
mination coefficient between 3P++ and 3P + analyses
was increased from 0.739 (Figure 3A) to 0.975 (Figure 8);
the latter is comparable to r2 of the intra-subject k3 cor-
relation (0.982; Figure 2A).
Such an estimation of parameter k3′ is not always prac-
tical, as 3P + analysis with arterial input function is neces-
sary for individual cerebellar k3 estimation. However, these
results suggest that the lower r2 in the inter-subject correl-
ation compared with the intra-subject correlation is due to
the sample variance of cerebellar k3 and that 3P++ analysis
itself is robust, as far as the reference is ideal.
Practically, the use of mean k3r may be meaningful.
When target k3 is empirically corrected as corrected k3 =
estimated k3 +mean cerebellar k3, the absolute bias in tar-
get k3 would decrease. However, the precision of target k3
would not necessarily be improved owing to the variance
of individual k3r.
In addition to the nonzero effect of k3r, inter-subject
variation of k2r from the fixed value (k2 = 0.178/min)
may also produce individually different k3 bias in 3P++
analysis, resulting in lower inter-subject k3 correlation
between 3P + and 3P++ analyses.
Limitations of 3P++ analysis
When 3P++ analysis was applied to [11C]PIB as an ex-
ample of moderately reversible ligands, a somewhat lower
inter-subject k3 correlation (r
2 = 0.739 or 0.711; Figure 3A
or Figure 3B) was shown between the 3P++ and 3P + or
4P analyses, respectively, across a k3 range including NC
and AD (3P + k3, 0.004 to 0.040/min). The rank order of
3P++ k3 also differed considerably from 3P + k3 or 4P k3.
These results were mainly due to nonzero k3r and the
sample variance of both k2r and k3r as described above.
The negative k3 bias (3P++ vs. 3P+) was larger in NC ROI
(−70%) than in AD ROI (−48%) when k3r = 0.008/min
(Figure 7). The previous report showed that the difference
in k3 bias (28-min 3P + vs. 90-min 4P) was small between
NC ROI (−23%) and AD ROI (−24%) [13]. Therefore, the
k3 value in 3P++ analysis may be somewhat underesti-
mated in the ROI with lower amyloid deposition com-
pared to 3P + or 4P analysis.
In [11C]PIB PET, 3P++ analysis may be inadequate
for inter-subject k3 comparison and useful only for
intra-subject (inter-ROI) comparison or pre- vs. post-
comparison in the same subject. 3P++ analysis would
be more suitable for such reversible ligands that have
moderate k4 and reference tissue without specific binding.
Conclusions
The 3P++ analysis is a k3 estimation method for mod-
erately reversible PET ligands with a short scan timesuch as 40 min and without arterial blood sampling.
Although the applicability of 3P++ method to [11C]PIB
PET may be restricted to intra-subject comparison,
3P++ analysis itself is robust. The 3P++ method would
be useful for PET study with non-highly reversible li-
gands, as far as the reference tissue without specific
binding is available.
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